Darwinian Theory

As one of the evolutionary biologists quoted in a recent article (R. Lewis, The Scientist, May 12, 1997, page 13), I must challenge Michael Behe's response (M. Behe, The Scientist, June 9, 1997, page 10) that scientists should confess to being "substantially in the dark" about the cause of evolution. Teaching evolution is already hard enough without feigning ignorance about a fundamental principle of life. Behe criticizes Lewis for "conflating different concepts under the single term of 'evolu

Written byDavid King
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

As one of the evolutionary biologists quoted in a recent article (R. Lewis, The Scientist, May 12, 1997, page 13), I must challenge Michael Behe's response (M. Behe, The Scientist, June 9, 1997, page 10) that scientists should confess to being "substantially in the dark" about the cause of evolution. Teaching evolution is already hard enough without feigning ignorance about a fundamental principle of life.

Behe criticizes Lewis for "conflating different concepts under the single term of 'evolution.'" But Behe's attempt to deflate the Darwinian mechanism as "the least-supported" concept of evolution only demonstrates an inadequate grasp of what a theory is. Behe believes that a single fossil Tyrannosaur "conclusively proves" the occurrence of change over time, while modern experiments give "no reason" for thinking that variation and selection are "capable of building marvels." But unlike the circumstantial evidence and chain of inference that support descent with modification (which were ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies